Medicine information
Uses & overview
ST- GLIPTIN DAPA 50/5 is a combination antidiabetic medicine from Steris Healthcare Pvt. Ltd. It contains Dapagliflozin 5 mg and Sitagliptin Phosphate equivalent to Sitagliptin 50 mg, as specified on the approved product label. This combination may be prescribed to help manage blood glucose levels in adults with type 2 diabetes mellitus when a healthcare professional considers both medicines appropriate. The two active ingredients work through different mechanisms to support blood sugar control. Dapagliflozin 5 mg: Belongs to a class of medicines called SGLT2 inhibitors. It helps the kidneys remove excess glucose from the body through urine. Sitagliptin 50 mg: Belongs to a class of medicines called DPP-4 inhibitors. It helps regulate incretin hormones, supporting glucose-dependent insulin release and helping reduce excess glucose production. Together, these ingredients can support blood glucose management when combined with a suitable diet, regular physical activity, and routine medical monitoring. Product Information Brand name: ST- GLIPTIN DAPA 50/5 Composition: Dapagliflozin 5 mg + Sitagliptin Phosphate 50 mg Dosage form: Tablets Therapeutic category: Oral antidiabetic combination Primary use: Blood glucose management in adults with type 2 diabetes mellitus Company: Steris Healthcare Pvt. Ltd. Important precautions: This medicine is not intended for type 1 diabetes or the treatment of diabetic ketoacidosis. It may not be suitable for people with certain kidney conditions, dehydration, or other medical concerns. A healthcare professional should review kidney function, existing medical conditions, and other medicines before prescribing treatment. Continue recommended dietary measures, physical activity, and blood glucose monitoring during treatment.
How to use
Take ST- GLIPTIN DAPA 50/5 exactly as prescribed by your doctor. Follow the recommended dose and timing, and take the tablet with or without food according to your doctor's instructions and the approved product information. Swallow the tablet with water. Do not change the dose, stop treatment, or take additional tablets without medical advice. If you miss a dose, follow your doctor's or pharmacist's instructions and do not double the next dose. Maintain a balanced diet, exercise regularly as advised, and monitor your blood glucose levels according to your healthcare professional's recommendations. Drink adequate fluids unless your doctor has advised you to restrict fluid intake. Inform your doctor if you develop persistent vomiting, diarrhoea, reduced food or fluid intake, or symptoms of dehydration. Seek urgent medical attention for unusual abdominal pain, nausea, rapid or difficult breathing, or severe weakness, as these can indicate a serious complication. Tell your healthcare professional about all medicines and supplements you use. Attend scheduled follow-up appointments so your treatment and kidney function can be reviewed when necessary.
Storage
Store ST- GLIPTIN DAPA 50/5 in its original packaging in a cool, dry place, away from excessive heat, moisture, and direct sunlight. Keep the medicine out of the reach of children. Check the expiry date before use and do not take tablets that are expired or damaged. Follow the storage conditions printed on the product packaging.
